Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Circulating Tumor Cell Dx Is Technology To Watch In 2009 – Cleveland Clinic

This article was originally published in The Gray Sheet

Executive Summary

Use of circulating tumor cell assays to predict chemotherapy success will be the most significant medical innovation to break through in 2009, a panel of Cleveland Clinic physicians predicts
Advertisement

Related Content

Bone Conduction Hearing Device Is Tech To Watch In 2010 - Cleveland Clinic
Bone Conduction Hearing Device Is Tech To Watch In 2010 - Cleveland Clinic
Research In Brief
Research In Brief
Study Shows Circulating Tumor Cell Chips Track Cancer Drug Response
Study Shows Circulating Tumor Cell Chips Track Cancer Drug Response
Advertisement
UsernamePublicRestriction

Register

MT026791

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel